Institutional members access full text with Ovid®

Share this article on:

Multiple Sclerosis: B Cells Take Center Stage

Pröbstel, Anne-Katrin, MD; Hauser, Stephen, L., MD

doi: 10.1097/WNO.0000000000000642
Bench to Bedside: PDF Only

Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California.

Address correspondence to Stephen L. Hauser, MD, Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco (UCSF), 675 Nelson Rising Lane, San Francisco, CA 94158; E-mail: stephen.hauser@ucsf.edu

A.-K. Pröbstel is supported by a postdoctoral fellowship from the Swiss National Science Foundation (P2SKP3_164938/1; P300PB_177927). S.L. Hauser receives funding from the National Institutes of Health (NIH) (R01NS026799; R01NS049477), the National Multiple Sclerosis Society (NMSS) (RG2899) and the Conrad N. Hilton Foundation.

A.-K. Pröbstel received travel reimbursement from Genzyme, Baxalta, and Merck and speaker honoraria from Bayer used for research support. S. L. Hauser serves on the Scientific Advisory Boards of Annexon, Bionure, Symbiotix, and Molecular Stethoscope, and on the Board of Trustees of Neurona; and also reports receiving travel reimbursement and writing assistance from F. Hoffmann-La Roche for CD20-related meetings and presentations.

© 2018 by North American Neuro-Ophthalmology Society